In Brief: OTC label reform
This article was originally published in The Tan Sheet
Executive Summary
OTC label reform: Internal FDA committee on OTC label reform met for the first time during the week of June 11 to discuss how to proceed toward a regulatory proposal on OTC label reform. In a June 9 "Talk Paper," FDA noted the increasing acceptance of consumer friendly labeling by the OTC industry and said that "the agency is encouraging this trend and expects in the future to publish a proposal for a new, more useful OTC drug label in the Federal Register." In addition to its use by J&J/Merck's Pepcid AC and SmithKline Beecham's Tagamet HB, the new labeling format also is being adopted by manufacturers of non-switch OTCs. Thompson Medical plans to have its full line of OTCs in consumer friendly labeling by the end of 1995 ("The Tan Sheet" May 22, In Brief)..
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning